Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).

Pyritinol hydrochloride (encephabol) and senile dementia.

Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer type and multiinfarct dementia.

BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD).

Efficacy of naftidrofuryl in patients with moderate senile dementia.

Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.

Memory and attention in patients with senile dementia of the Alzheimer type and in normal elderly subjects.

Circulating suppressing factor for the muscarinic acetylcholine receptor in patients with senile dementia of the Alzheimer type.

Depression and senile dementia of the Alzheimer type: a role for moclobemide.

Clinical effects of choline in Alzheimer senile dementia.

Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.

Survival of outpatients with Alzheimer-type dementia.

Abnormal EEG slow activity in left temporal areas in senile dementia of the Alzheimer type.

Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study.

Agraphia in dementia of the Alzheimer type.

Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.

Mild senile dementia of the Alzheimer type: 3. Longitudinal and cross-sectional assessment.

Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types?

Correlation between mini-mental state examination and quantitative electroencephalography in senile dementia of Alzheimer type.

Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention.

Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.

[Comparative study by computerized EEG of dementia of the ALzheimer type and Parkinson's disease with dementia].

Lateral hemispheric asymmetries in senile dementia of Alzheimer's type (SDAT) assessed by I-123 IMP SPECT imaging: a preliminary report.

Blood glucose and insulin response in patients with senile dementia of the Alzheimer's type.

Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.

Suggest Documents

Pyritinol hydrochloride (encephabol) and senile dementia.

Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer type and multiinfarct dementia.

BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD).

Efficacy of naftidrofuryl in patients with moderate senile dementia.

Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.

Memory and attention in patients with senile dementia of the Alzheimer type and in normal elderly subjects.

Circulating suppressing factor for the muscarinic acetylcholine receptor in patients with senile dementia of the Alzheimer type.

Depression and senile dementia of the Alzheimer type: a role for moclobemide.

Clinical effects of choline in Alzheimer senile dementia.

Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.

Survival of outpatients with Alzheimer-type dementia.

Abnormal EEG slow activity in left temporal areas in senile dementia of the Alzheimer type.

Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study.

Agraphia in dementia of the Alzheimer type.

Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.

Mild senile dementia of the Alzheimer type: 3. Longitudinal and cross-sectional assessment.

Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types?

Correlation between mini-mental state examination and quantitative electroencephalography in senile dementia of Alzheimer type.

Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention.

Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.

[Comparative study by computerized EEG of dementia of the ALzheimer type and Parkinson's disease with dementia].

Lateral hemispheric asymmetries in senile dementia of Alzheimer's type (SDAT) assessed by I-123 IMP SPECT imaging: a preliminary report.

Blood glucose and insulin response in patients with senile dementia of the Alzheimer's type.

Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.

Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).

Recommend Documents

Follow Us